Advarra

JUNE 27, 2023

The goal is to identify safer, more effective methods of treating illnesses using new drugs or new combinations of existing drugs. A clinical trial investigating a drug or therapy is typically divided into four phases: Phase I, Phase II, Phase III, and Phase IV.

Clinical Research 52

Clinical Research Research Clinical Trials Trials 52

Drug Discovery World

JUNE 9, 2023

There has been some interesting news related to clinical trials this week, with the announcement that the FDA has published draft guidance to modernise the design and conduct of studies, and the failure of Bellerophon Therapeutics’ Phase III study in fibrotic Interstitial Lung Disease.

Clinical Trials 130

Clinical Trials FDA Trials Drugs 130

Drug Discovery World

FEBRUARY 10, 2023

Clinical drug trials have made the headlines this week, as it was revealed that breast cancer still tops the bill for number of clinical studies and the shortcomings in current methods to ensure representation of patient populations in trials were exposed.

Clinical Trials 130

Clinical Trials Trials Drugs Vaccine 130

Drug Discovery World

FEBRUARY 20, 2023

Results from the PROVENT Phase III trial showed a significant reduction in the risk of developing symptomatic Covid-19 and that the protection continued for at least six months. Prostate cancer A new metastatic prostate cancer drug was approved by the FDA in March, followed by the European Commission in December.

Trials 130

Trials Drug Trials Disease Clinical Trials 130

Conversations in Drug Development Trends

NOVEMBER 3, 2022

BioPharma Dive interviewed our Derek Ansel on how to conduct psychedelic clinical research. In April 2022, the Food and Drug Administration (FDA) issued draft guidance on developing a “Race and Ethnicity Diversity Plan” for clinical trials. Looking to diversify the reach of your orphan drug trial?

Disease 52

Disease Clinical Trials Trials International 52

PPD

MARCH 28, 2024

With fierce competition for available capital and resources, investors expect a clear demonstration of return on investment (ROI) — a factor on prominent display in industry research conducted by the PPD clinical research business of Thermo Fisher Scientific.

Trials 52

Trials Clinical Trials Drug Development Clinical Research 52

The Pharma Data

NOVEMBER 10, 2020

“They will help researchers mechanistically assess target engagement in clinical trials,” and also will be used in clinical practice to identify the right drugs for the right patients, Howard Fillet, M.D., Importantly, “It demonstrated a lack of drug interference for each drug studied,” Dage said.

Disease 52

Disease Clinical Trials Trials Research 52